Literature DB >> 16787405

Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit.

Sylvie Bretin1, Véronique Rogemond, Philippe Marin, Marion Maus, Yvette Torrens, Jérôme Honnorat, Jacques Glowinski, Joël Prémont, Christian Gauchy.   

Abstract

The brain is particularly vulnerable to ischaemia; however, neurons can become tolerant to ischaemic insult. This tolerance has been shown to involve activation of NMDA receptors, but its mechanisms have not yet been fully elucidated. Using a preconditioning protocol, we show that neurons surviving to a transient NMDA exposure become resistant to the glutamatergic agonist. Using a proteomic approach, we found that alterations of the protein pattern of NMDA-resistant neurons are restricted mainly to the five collapsin response mediator proteins (CRMPs). A sustained increase in calpain activity following NMDA treatment is responsible for the production of cleaved CRMPs. Finally, we provide evidence for the involvement of the cleaved form of WT-CRMP2 in the down-regulation of NR2B. Our data suggests that, beside their role in neuronal morphogenesis, CRMPs may contribute to neuronal plasticity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787405     DOI: 10.1111/j.1471-4159.2006.03969.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  30 in total

1.  Preconditioning with Ginkgo biloba (EGb 761®) provides neuroprotection through HO1 and CRMP2.

Authors:  Shadia E Nada; Zahoor A Shah
Journal:  Neurobiol Dis       Date:  2012-01-24       Impact factor: 5.996

Review 2.  Collapsin response mediator proteins regulate neuronal development and plasticity by switching their phosphorylation status.

Authors:  Naoya Yamashita; Yoshio Goshima
Journal:  Mol Neurobiol       Date:  2012-02-18       Impact factor: 5.590

3.  Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2).

Authors:  Joel M Brittain; Liang Chen; Sarah M Wilson; Tatiana Brustovetsky; Xiang Gao; Nicole M Ashpole; Andrei I Molosh; Haitao You; Andy Hudmon; Anantha Shekhar; Fletcher A White; Gerald W Zamponi; Nickolay Brustovetsky; Jinhui Chen; Rajesh Khanna
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

4.  NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus.

Authors:  Rana A Al-Hallaq; Thomas P Conrads; Timothy D Veenstra; Robert J Wenthold
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

5.  CRMP3 is required for hippocampal CA1 dendritic organization and plasticity.

Authors:  Tam T Quach; Guy Massicotte; Marie-Françoise Belin; Jérome Honnorat; Erica R Glasper; Anne C Devries; Lyn B Jakeman; Michel Baudry; Anne-Marie Duchemin; Pappachan E Kolattukudy
Journal:  FASEB J       Date:  2007-09-04       Impact factor: 5.191

6.  Disruption of NMDAR-CRMP-2 signaling protects against focal cerebral ischemic damage in the rat middle cerebral artery occlusion model.

Authors:  Joel M Brittain; Rui Pan; Haitao You; Tatiana Brustovetsky; Nickolay Brustovetsky; Gerald W Zamponi; Wei-Hua Lee; Rajesh Khanna
Journal:  Channels (Austin)       Date:  2012-01-01       Impact factor: 2.581

Review 7.  Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.

Authors:  Li Shan Chiu; Ryan S Anderton; Neville W Knuckey; Bruno P Meloni
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

8.  Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy.

Authors:  Mitra Tavakoli; Omar Asghar; Uazman Alam; Ioannis N Petropoulos; Hassan Fadavi; Rayaz A Malik
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

9.  Identification and structural analysis of C-terminally truncated collapsin response mediator protein-2 in a murine model of prion diseases.

Authors:  Fumiko Shinkai-Ouchi; Yoshio Yamakawa; Hideyuki Hara; Minoru Tobiume; Masahiro Nishijima; Kentaro Hanada; Ken'ichi Hagiwara
Journal:  Proteome Sci       Date:  2010-10-20       Impact factor: 2.480

Review 10.  Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.

Authors:  P S Vosler; C S Brennan; J Chen
Journal:  Mol Neurobiol       Date:  2008-08-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.